Select Page

The following links will download a Word file:

November 2019 Activity Report

Edinburgh Immunoparmacology Meeting Report 2018

April 2015 Activity Report Immunopharmacology Section

March 2014 Activity Report Immunopharmacology Section

October 2013 Workshop on Immunopharmacology and Biotechnology in Cuba

March 2013 Activity Report Immunopharmacology Section

January 2013 Approval of Bylaws

November 2012 Section Proposal

 

Immuphar Publications:

  1. “Immunopharmacology and Inflammation” published by Springer, edited by Section members C. Riccardi, F. Levi-Schaffer, E. Tiligada, 2018.
  2. Harding SD, Faccenda E, Southan C, Maffia P, Davies JA. A new guide to immunopharmacology. Nat Rev Immunol. 2018;18(12):729. doi: 10.1038/s41577-018-0079-2.
  3. Maffia P, Mantovani A, Spedding M. Scientists on the Spot: the Guide to Immunopharmacology as a new resource for the cardiovascular community. Cardiovasc Res. 2019 Jan 1;115(1):e5-e6. doi: 10.1093/cvr/cvy296.
  4. Tavares LP, Peh HY, Tan WSD, Pahima H, Maffia P, Tiligada E, Levi-Schaffer F. Granulocyte-targeted therapies for airway diseases. Pharmacol Res. 2020 Jul;157:104881. doi: 10.1016/j.phrs.2020.104881.
  5. Morimoto A, Kikuta J, Ishii M. Intravital multiphoton microscopy as a novel tool in the field of Immunopharmacology. Pharmacol Ther. 2020 206:10729. doi: 10.1016/j.pharmthera.2019.107429.
  6. Harding SD, Faccenda E, Southan C, Pawson AJ, Maffia P, Alexander SPH, Davenport AP, Fabbro D, Levi-Schaffer F, Spedding M, Davies JA. The IUPHAR guide to immunopharmacology: connecting immunology and pharmacology. Immunology. 2020 May;160(1):10-23. doi: 10.1111/imm.13175.
  7. Milling S, Spedding M, Maffia P. Guide to Immunopharmacology: a database to boost immunology education, research and therapy. Immunology. 2020 May;160(1):1-2. doi: 10.1111/imm.13201.
  8. Alexander SPH, Armstrong JF, Davenport AP, Davies JA, Faccenda E, Harding SD, Levi-Schaffer F, Maguire JJ, Pawson AJ, Southan C, Spedding M. A rational roadmap for SARS-CoV/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29. Br J Pharmacol. 2020. 177(21):4942-4966. doi: 10.1111/bph.15094.
  9. Levi-Schaffer F, de Marco A. COVID-19 and the revival of passive immunization: Antibody therapy for inhibiting SARS-CoV-2 and preventing host cell infection: IUPHAR review: 31. Br J Pharmacol. 2021 Jan 5 doi: 10.1111/bph.15359.
  10. Spedding, M., Levi-Schaffer F. The impact of COVID-19 on research, vaccines and drugs: a key role for pharmacology. August 2021 issue of Pharmacology Today.
  11. Wainwright CL, Teixeira MM, Adelson DL, Buenz EJ, David B, Glaser KB, Harata-Lee Y, Howes MR, Izzo AA, Maffia P, Mayer AM, Mazars C, Newman DJ, Nic Lughadha E, Pimenta AM, Parra JA, Qu Z, Shen H, Spedding M, Wolfender JL. Future directions for the discovery of natural product-derived immunomodulating drugs: An IUPHAR positional review. Pharmacol Res. 2022. 177:106076. doi: 10.1016/j.phrs.2022.106076.
  12. Comprehensive Pharmacology. vol. 5. (Tiligada, K., Ed. Immunopharmacology/Musculoskeletal System Pharmacology, Kenakin, T., Ed-in-Chief), Elsevier Inc., 304-320. ISBN: 978-0-12-820876-2.
  13. Barrett MP. The legacy of penicillin’s first patient. Pharmacol Res. 2023 Jun;192:106772. doi: 10.1016/j.phrs.2023.106772.
  14. Peh HY, Gurgone D, Maffia P. Immunopharmacology sessions at the 19th World Congress of Basic & Clinical Pharmacology 2023. Pharmacol Res. 2023 Oct;196:106911. doi: 10.1016/j.phrs.2023.106911.